title: [Infectious disease prevention and occupational-disability insurance for medical students].
abstract: OBJECTIVE
  To gain insight into the rate of immunization for hepatitis B and the status of infectious-disease prevention among Dutch medical students working in areas where HIV is endemic. Additionally, to provide an overview of the preparedness of medical schools in the Netherlands to collaborate in the development of a collective occupational disability insurance for their students.
  
  
  METHODS
  Literature review and survey.
  
  
  METHODS
  A questionnaire was sent to all 8 Dutch medical schools in 2003 and a follow-up telephone interview was conducted in July 2005. The results of this survey were compared with the international scientific literature, which was systematically searched using PubMed, Web of Science and Picarta up to and including March 2005.
  
  
  RESULTS
  There was a great deal of international variation in the proven degree of immunization against hepatitis B. Infectious-disease prevention measures for students on rotation in HIV-endemic areas left much to be desired. Occupational-disability insurance for students who started their clinical rotations was described, particularly in the United States, but details on participation and costs were lacking. In 2003 there were considerable differences between medical schools in the Netherlands regarding hepatitis-B immunization. However, in 2005, all schools reported the implementation of a new national hepatitis-B immunization protocol. Compared to 2003, most schools reported higher safety standards for electives in HIV-endemic areas and post-exposure prophylaxis was more frequently made available at no cost. Individual preparation for these electives still occurred infrequently. None of the medical schools were pursuing a policy of providing occupational disability insurance for students from the beginning of their clinical rotations.
authors.affiliation: Universiteit van Amsterdam, Bureau Studentenartsen, Oude Turfmarkt GC Amsterdam. c.b.t.rietmeijer@uva.nl
authors.forename: C B T
authors.initials: CB
authors.lastname: Rietmeijer
authors.forename: C R L
authors.initials: CR
authors.lastname: Boot
authors.forename: C A M
authors.initials: CA
authors.lastname: Rietmeijer
authors.forename: P
authors.initials: P
authors.lastname: Vonk
authors.forename: F J
authors.initials: FJ
authors.lastname: Meijman
mesh_terms: D003140:Communicable Disease Control; D004504:Education, Medical, Undergraduate; D015658:HIV Infections / Q000453:epidemiology / Q000635:transmission; D006509:Hepatitis B / Q000517:prevention & control; D006801:Humans; D018868:Insurance, Disability; D009426:Netherlands; D016273:Occupational Exposure / Q000517:prevention & control*; D013337:Students, Medical; D011795:Surveys and Questionnaires; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage
chemical_list: D014761:Viral Hepatitis Vaccines